117007-77-9Relevant articles and documents
THERAPEUTIC COMPOUNDS AND COMPOSITIONS FOR TREATING SOCIAL DISORDERS AND SUBSTANCE USE DISORDERS
-
Paragraph 0170, (2017/01/26)
Disclosed herein are compounds, compositions and methods for the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders. In particular, disclosed herein are com
Pyrazolo[1,4]diazepines as non-peptidic probes of the oxytocin and vasopressin receptors
Reekie, Tristan A.,McGregor, Iain S.,Kassiou, Michael
supporting information, p. 4568 - 4571 (2015/01/09)
An improved synthesis of differently substituted pyrazolo[1,4]diazepine compounds is reported. In addition, we have used this methodology to obtain non-peptidic compounds to probe the oxytocin and vasopressin receptors.
SUBSTITUTED BICYCLOCARBOXYAMIDE COMPOUNDS
-
Page/Page column 49-50, (2008/12/05)
This invention provides a compound of the formula (I). These compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor such as pain, or the like in mammal. This invention also provides a pharmaceutical composition comprising the above compound.